PTC Therapeutics Inc
(NAS:PTCT)
$
35.81
-1.09 (-2.95%)
Market Cap: 2.75 Bil
Enterprise Value: 2.28 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 70/100 - Q1 2024 PTC Therapeutics Inc Earnings Call TranscriptApr 25, 2024$25.49 (+1.11%)Earnings
- Q4 2023 PTC Therapeutics Inc Earnings Call TranscriptFeb 29, 2024$28.19 (-0.04%)Earnings
- Q3 2023 PTC Therapeutics Inc Earnings Call TranscriptOct 26, 2023$23.95 (+2.88%)Earnings
- Royalty Pharma PLC With PTC Therapeutics Inc To Acquire Additional Royalties On Roches Evrysdi Call TranscriptOct 19, 2023
- PTC Therapeutics Inc CHMP Opinion on Translarna Call TranscriptSep 15, 2023
- PTC Therapeutics Inc at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 PTC Therapeutics Inc Earnings Call TranscriptAug 03, 2023$40.32 (+0.30%)Earnings
- PTC Therapeutics Inc Phenylketonuria (PKU) and Sepiapterin - Corporate Call TranscriptJul 19, 2023
- PTC Therapeutics Inc PIVOT-HD Interim Data Update Call TranscriptJun 21, 2023
- PTC Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- PTC Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- PTC Therapeutics Inc MOVE-FA Topline Results-Call TranscriptMay 23, 2023
- PTC Therapeutics Inc APHENITY Topline Results Call TranscriptMay 17, 2023
- Q1 2023 PTC Therapeutics Inc Earnings Call TranscriptApr 27, 2023$52.64 (+0.77%)Earnings
- PTC Therapeutics Inc CEO Appointment - Corporate Call TranscriptMar 24, 2023
- PTC Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 PTC Therapeutics Inc Earnings Call TranscriptFeb 21, 2023$44.72 (-4.20%)Earnings
- PTC Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Q3 2022 PTC Therapeutics Inc Earnings Call TranscriptOct 27, 2022$44.59 (-2.32%)Earnings
- PTC Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 PTC Therapeutics Inc Earnings Call TranscriptAug 04, 2022$49.23 (+2.95%)Earnings
- PTC Therapeutics Inc Call to Review Topline Results from Study 041 of Translarna™ (Ataluren) TranscriptJun 21, 2022
- PTC Therapeutics Inc to Discuss the Positive Opinion from the CHMP on its AADC Deficiency Gene Therapy TranscriptMay 23, 2022
- PTC Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 PTC Therapeutics Inc Earnings Call TranscriptMay 03, 2022$35.76 (-1.16%)Earnings
- PTC Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 17, 2022
- Q4 2021 PTC Therapeutics Inc Earnings Call TranscriptFeb 22, 2022$38.45 (-1.56%)Earnings
- PTC Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- PTC Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2021
- Q3 2021 PTC Therapeutics Inc Earnings Call TranscriptOct 28, 2021$36.44 (+2.79%)Earnings
- PTC Therapeutics Inc PTC518 Phase 1 Huntington's Disease Program Update Conference Call TranscriptSep 23, 2021
- PTC Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 PTC Therapeutics Inc Earnings Call TranscriptJul 29, 2021$38.24 (-3.09%)Earnings
- PTC Therapeutics Inc Annual Shareholders Meeting TranscriptJun 08, 2021
- PTC Therapeutics Inc at UBS Global Healthcare Virtual Conference TranscriptMay 26, 2021
- PTC Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 PTC Therapeutics Inc Earnings Call TranscriptMay 04, 2021$38.47 (-5.64%)Earnings
- PTC Therapeutics Inc to Host PTC518 Huntington Disease Deep Dive Webinar TranscriptApr 15, 2021
- PTC Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 10, 2021
- Q4 2020 PTC Therapeutics Inc Earnings Call TranscriptFeb 25, 2021$55.19 (-4.23%)Earnings
- PTC Therapeutics Inc Duchenne Community Update Call TranscriptFeb 11, 2021
- PTC Therapeutics Inc Corporate Call - Translarna™Study 045 and Clinical Update TranscriptFeb 04, 2021
- PTC Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- PTC Therapeutics Inc Translarna Deep Dive TranscriptDec 15, 2020
- PTC Therapeutics Inc at Barclays Virtual Gene Editing & Gene Therapy Summit TranscriptNov 16, 2020
- PTC Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2020
- Q3 2020 PTC Therapeutics Inc Earnings Call TranscriptOct 29, 2020$53.89 (+2.71%)Earnings
- Q2 2020 PTC Therapeutics Inc Earnings Call TranscriptAug 05, 2020$48.97 (+0.99%)Earnings
- PTC Therapeutics Inc Splicing Deep Dive TranscriptJul 24, 2020
- PTC Therapeutics Inc To Monetize Portion of Risdiplam Royalty Stream For $650 Million From Royalty Pharma PLC Call TranscriptJul 20, 2020
- PTC Therapeutics Inc Corporate Call - PTC299 for the Potential Treatment of COVID-19 TranscriptJun 17, 2020
- PTC Therapeutics Inc Annual Shareholders Meeting TranscriptJun 10, 2020
- PTC Therapeutics Inc Bio-e Deep Dive Webinar TranscriptJun 05, 2020
- PTC Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- PTC Therapeutics Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 PTC Therapeutics Inc Earnings Call TranscriptApr 30, 2020$50.92 (-4.89%)Earnings
- PTC Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 10, 2020
- Q4 2019 PTC Therapeutics Inc Earnings Call TranscriptMar 02, 2020$54.93 (+0.16%)Earnings
- PTC Therapeutics Inc SUNFISH Part 2 Risdiplam (RG7916) Results - Corporate Call TranscriptFeb 06, 2020
- PTC Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- PTC Therapeutics Inc at Evercore HealthCONx Conference TranscriptDec 03, 2019
- PTC Therapeutics Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 PTC Therapeutics Inc Earnings Call TranscriptOct 29, 2019$39.31 (-1.65%)Earnings
- PTC Therapeutics Inc at Jefferies Gene Therapy Summit TranscriptOct 08, 2019
- Q2 2019 PTC Therapeutics Inc Earnings Call TranscriptAug 06, 2019$44.75 (+4.90%)Earnings
- PTC Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 PTC Therapeutics Inc Earnings Call TranscriptMay 02, 2019$37.38 (+2.98%)Earnings
- PTC Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 14, 2019
- Q4 2018 PTC Therapeutics Inc Earnings Call TranscriptFeb 28, 2019$34.54 (-1.96%)Earnings
PTC Therapeutics Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 12, 2020 / 07:40PM GMT
Release Date Price:
$47.36
(+0.64%)
Tazeen Ahmad
BofA Merrill Lynch, Research Division - VP
Good afternoon, everyone. Thanks for joining us at the Bank of America Healthcare Conference. Of course, I am Tazeen Ahmad. I am one of the senior biotech analysts at the firm. It's my pleasure to have our next presenting company, PTC Therapeutics.
Speaking for PTC this afternoon are several members from the management team, Chief Executive, Stu Peltz; Chief Financial Officer, Emily Hill; as well as Chief Development Officer, Matt Klein. Thanks, guys, for joining us. Good afternoon.
Stuart W. Peltz
PTC Therapeutics, Inc. - Co-Founder, CEO & Executive Director
Thanks for having us.
Emily Luisa Hill
PTC Therapeutics, Inc. - CFO & Treasurer
Thanks, Tazeen.
Tazeen Ahmad
BofA Merrill Lynch, Research Division - VP
So maybe, Stu, we could start with a brief intro of the company, maybe a couple of minutes for anyone on the line who may not be as familiar with your story. Just talk about what PTC does.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)